Skip to main content

Part of the book series: Molekulare Medizin ((MOLMED))

  • 171 Accesses

Zusammenfassung

Der Serumkalziumspiegel wird in engen Grenzen (2,2-2,6 mM) konstant gehalten. Die Konstanz der extrazellulären Kalziumkonzentration ist für eine Reihe von Stoffwechselvorgängen im Körper essenziell: die Modulation der Sekretion von Hormonen und anderen Substanzen, die Erregbarkeit von Nervenzellen und die Konstanz der Nervenleitfähigkeit, die Zellproliferation, die Blutgerinnung, bei der Kalzium ein Kofaktor ist, die Modulation von zahlreichen Enzymen z.B. der Glukoneogenese, der Glykogenolyse und der Mineralisierung von neu gebildeter Knochengrundsubstanz. Die Änderung der Serumkalziumkonzentration durch die Hormone der Kalziumhomöostase, Parathormon (PTH) und Vitamin-Ir-Hormon [1,25-Dihydroxycholecalciferol: 1,25(OH)2D3], innerhalb des Normbereichs dient zur Modulation dieser verschiedenen Stoffwechselfunktionen (Hurwitz 1996).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aaltonen J, Bjorses P, Sandkuijl L, Perheentupa J, Peltonen L (1994) An autosomal locus causing autoimmune disease, autoimmune polyglandular disease typ I assigned to chromosome 21. Nat Genet 8:83–87

    Article  PubMed  CAS  Google Scholar 

  • Abdel AY, Auger LT, El-Gharbawy F (1989) Kenny-Caffey syndrome. Case report and literature review. Clin Pediatr (Phila) 28:175–179

    Article  Google Scholar 

  • Abramowicz MJ, Cochaux P, Cohen LH, Vamos E (1996) Pernicious anaemia and hypoparathyroidism in a patient with Kearns-Sayre syndrome with mitochondrial DNA duplication. J Inherit Metab Dis 19:109–111

    Article  PubMed  CAS  Google Scholar 

  • Agarwal SK, Kester MB, Debelenko LV et al. (1997) Germline mutat ions of the MEN 1 gene in familial multiple endocrine neoplasia type land related states. Hum Mol Genet 6:1169–1175

    Article  PubMed  CAS  Google Scholar 

  • Ahonen P (1985) Autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED): autosomal recessive inheritance. Clin Genet 27:535–542

    Article  PubMed  CAS  Google Scholar 

  • Ahonen P, Myllarniemi S, Sipila I, Perheentupa J (1990) Clinical variation of autoimmune polyendocrinopathycandidiasis-ectoderrnal dystrophy (APECED) in aseries of 68 patients. N Engl J Med 322:1829–1836

    Article  PubMed  CAS  Google Scholar 

  • Arnold A, Kim HG (1989) Clonal loss of one chromosome 11 in a parathyroid adenom a. J Clin Endocrinol Metab 69:496–499

    Article  PubMed  CAS  Google Scholar 

  • Arnold A, Staunton CE, Kim HG, Gaz RD, Kronenberg HM (1988) Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N Engl J Med 318:658–662

    Article  PubMed  CAS  Google Scholar 

  • Arnold A, Kim HG, Gaz RD et al. (1989) Molecular cloning and chromosomal mapping of DNA rearranged with parathyroid hormone in a parathyroid adenoma. J Clin Invest 83:2034–2040

    Article  PubMed  CAS  Google Scholar 

  • Arnold H, Horst SA, Gardella TJ, Baba H, Levine MA, Kronenberg HM (1990) Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism. J Clin Invest 86:1084–1087

    Article  PubMed  CAS  Google Scholar 

  • Arnold A, Brown MF, Urena P, Gaz RD, Sarfali E, Drueke TB (1995) Monoclonality of parathyro id tumors in chronic renal failure and primary parathyroid hyperplasia. J Clin Invest 95:2047–2053

    Article  PubMed  CAS  Google Scholar 

  • Asai N, Iwashita T, Matsuyama M, Takahashi M (1995) Mechanism of activation of the RET proto-oncogene by multiple endocrine neoplasia 2A mutat ions. Mol Cell Biol 15:1613–1619

    PubMed  CAS  Google Scholar 

  • Bai M, Janicic N, Trivedi S et al. (1997a) Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. J Clin Invest 99:1917–1925

    Article  PubMed  CAS  Google Scholar 

  • Bai M, Pearce SHS, Kifor O et al. (1997b) In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. J Clin Invest 99:88–96

    Article  PubMed  CAS  Google Scholar 

  • Berndt I, Reuter M, Salier B et al. (1998) A new hotspot for mutations in the RET proto-oncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab 83:770–774

    Article  PubMed  CAS  Google Scholar 

  • Blind E, Raue F, Götzmann J, Schmidt-Gayk H, Kohl B, Ziegler R (1992) Circulating levels of parathyroid hormonerelated protein in hypercalcemia of malignancy. Clin Endocrinol (Oxf) 37:290–297

    Article  CAS  Google Scholar 

  • Brown EM, Hebert SC (1997) Calcium-receptor-regulated parathyroid and renal function. Bone 20:303–309

    Article  PubMed  CAS  Google Scholar 

  • Brown EM, Pollack M, Seidman JG, Chou Y-HW, Riccardi D, Hebert SC (1995a) Calcium-ion-sensing cell-surface receptors. N Engl J Med 333:234–240

    Article  PubMed  CAS  Google Scholar 

  • Brown EM, Vassilev PM, Hebert SC (1995b) Calcium ions as extracellular messengers. Cell 83:679–682

    Article  PubMed  CAS  Google Scholar 

  • Budarf ML, Collins J, Gong W et al. (1995) Cloning a balanced translocation associated with DiGeorge syndrome and identification of a disrupted candidate gene. Nat Genet 10:269–278

    Article  PubMed  CAS  Google Scholar 

  • Capes-Davis A, Robinson BG (1999) Return of the native: deducing the normal function of the RET proto-oncogene. Curr Opin Endocrinol Diabetes 6:61–69

    Article  CAS  Google Scholar 

  • Carling T, Ridefelt P, Hellman P, Rastad J, Ackerström G (1997) Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism. J Clin Endocrinol Metab 82:1772–1775

    Article  PubMed  CAS  Google Scholar 

  • Carling T, Correa P, Hessman O et al. (1998) Parathyroid MEN 1 gene mutat ions in relation to clinical characteristies of non familial primary hyperparathyroidism. J Clin Endocrinol Metab 83:2960–2963

    Article  PubMed  CAS  Google Scholar 

  • Chandrasekharappa SC, Guru SC, Maniekam P et al. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276:404–407

    Article  PubMed  CAS  Google Scholar 

  • Chattopadhyay N, Vassilev PM, Brown EM (1997) Calciumsensing receptor: roles in and beyond systemic calcium homeost asis. Biol Chem 378:759–768

    PubMed  CAS  Google Scholar 

  • Chelly J, Concordet JP, Kaplan JC, Kahn A (1989) Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci USA86:2617–2621

    Article  PubMed  CAS  Google Scholar 

  • Cohen J, Gierlowsky TC, Schneider AB (1990) A prospective study of hyperparathyroidism in individuals exposed to radiation in childhood. JAMA 263:581–584

    Article  Google Scholar 

  • Cole DEC, Janicic N, Salisbury SR, Hendy GN (1997) Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciurie hypercalcemia: multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene. Am J Med Genet 71:202–210

    Article  PubMed  CAS  Google Scholar 

  • Cryns VL, Rubio M-P, Thor AD, Louis DN, Arnold A (1994a) p53 abnormalities in human parathyroid carcinoma. J Clin Endocrinol Metab 78:1320–1324

    Article  PubMed  CAS  Google Scholar 

  • Cryns VL, Thor A, Xu H-J et al. (1994b) Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. N Engl J Med 330:757–761

    Article  PubMed  CAS  Google Scholar 

  • Cryns VL, Yi SM, Tahara H, Gaz RD, Arnold A (1995) Frequent loss of chromosome arm 1p DNA in parathyroid adenomas. Genes Chromosomes Cancer 13:9–17

    Article  PubMed  CAS  Google Scholar 

  • De-Luca F, Ray K, Mancilla EE et al. (1997) Sporadie hypoparathyroidism caused by de novo gain-of function mutations of the Ca(2+)-sensing receptor. J Clin Endocrinol Metab 82:2710–2715

    Article  PubMed  CAS  Google Scholar 

  • Dionisi CV, Garavaglia B, Burlina AB et al. (1996) Hypoparathyroidism in mitochondrial trifunctional protein deficiency. J Pediatr 129:159–162

    Article  Google Scholar 

  • Dotzenrath C, Teh BT, Farnebo F et al. (1996) Allelic loss of the retinobla stoma tumor suppressor gene: a marker for aggressive parathyro id tumors? J Clin Endocrinol Metab 81:3194–3196

    Article  PubMed  CAS  Google Scholar 

  • Drenzer M, Neelon FA, Lebovitz HE (1973) Pseudohypoparathyroidism type II: a possible defect in the reception of the cyclie AMPsignal. N Engl J Med 289:1056–1060

    Article  Google Scholar 

  • Eng C, Clayton D, Schuffenecker I et al. (1996) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. JAMA 276:1575–1579

    Article  PubMed  CAS  Google Scholar 

  • Falchetti A, Bale AE, Amorosi A et al. (1993) Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab 76:139–144

    Article  PubMed  CAS  Google Scholar 

  • Falchetti A, Morelli A, Amorosi A et al. (1997) Allelic loss in parathyroid tumors from individuals homozygous for multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 82:2278–2282

    Article  PubMed  CAS  Google Scholar 

  • Farfel Z, Bourne HR, Iiri T (1999) The expanding spectrum of G protein diseases. N Engl J Med 340:1012–1020

    Article  PubMed  CAS  Google Scholar 

  • Farnebo F, Enberg U, Grimelius L et al. (1997a) Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism. J Clin Endocrinol Metab 82:3481–3486

    Article  PubMed  CAS  Google Scholar 

  • Farnebo F, Farnebo LO, Nordenström I, Larsson C (1997b) Allelic loss on chromosome 11 is uncommon in parathyroid glands of patients with hypercalcemic secondary hyperparathyroidism. Eur J Surg 163:331–337

    PubMed  CAS  Google Scholar 

  • Franceschini P, Testa A, Bogetti G et al. (1992) Kenny-Caffey snydrome in two sibs born to consanguineous parents: evidence of an autosomal recessive variant. Am J Med Genet 42:112–116

    Article  PubMed  CAS  Google Scholar 

  • Frank-Raue K, Höppner W, Frilling A et al. (1996) Mutations in the RET proto-oncogene in German MEN families: relation between genotype and phenotype. J Clin Endocrinol Metab 81:1780–1783

    Article  PubMed  CAS  Google Scholar 

  • Frank-Raue K, Höppner W, Buhr H, Herfarth C, Raue F (1997) Results and follow-up in eleven MEN 2A gene carriers after prophylactie thyroidectomy. Exp Clin Endocrinol Diabetes [Suppl 4] 105:76–78

    Google Scholar 

  • Friedman E, Bale AE, Marx SJ et al. (1990) Genetic abnormalities in sporadie parathyroid adenomas. J Clin Endocrinol Metab 71:293–297

    Article  PubMed  CAS  Google Scholar 

  • Friedman E, Marco L de, Gejman PVet al. (1992) Allelic loss from chromosome 11 in parathyroid tumors. Cancer Res 52:6804–6809

    PubMed  CAS  Google Scholar 

  • Friedman E, Sakaguchi K, Bale AE et al. (1989) Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med 321:213–218

    Article  PubMed  CAS  Google Scholar 

  • Fugazzola L, Pilotti S, Pinchera A et al. (1995) Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res 55:5617–5620

    PubMed  CAS  Google Scholar 

  • Fujiwara S, Sposto R, Ezaki H et al. (1992) Hyperparathyroidism among atomic bomb survivors in Hiroshima. Radiat Res 130:362–378

    Article  Google Scholar 

  • Fukomoto S, Suzawa M, Takeuchi Y et al. (1996) Absence of mutations in parathyroid hormone (PTH)/PTH-related protein receptor complementary deoxyribonucleic acid in patients with pseudohypoparathyroidism typ Ib. J Clin Endocrinol Metab 81:2554–2558

    Article  Google Scholar 

  • Fukuda N, Tanaka H, Tominaga Y, Fukagaw M, Kurokawa K, Seino Y (1993) Decreased 1,25-dihydroxy vitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92:1436–1443

    Article  PubMed  CAS  Google Scholar 

  • Fuleihan GE-H, Klerman EB, Brown EN, Choe Y, Brown EM, Czeisler CA (1997) The parathyroid hormone circadian rhythm is truly endogenous — a general clinical research center study. J Clin Endocrinol Metab 82:281–286

    Article  CAS  Google Scholar 

  • Fuleihan GE, Seifter J, Scott J, Brown EM (1998) Calciumregulated renal calcium handling in healthy men: relationsh ip to sodium handling. J Clin Endocrinol Metab 83:2366–2372

    Article  Google Scholar 

  • Fusco A, Grieco M, Santoro M et al. (1987) A new oncogene in human-thyroid papillary carcinoma and their lymph nodal metastases. Nature 328:170–172

    Article  PubMed  CAS  Google Scholar 

  • Gama L, Baxendale-Cox LM, Breitwieser GE (1997) Ca2+-sensing receptors in intestinal epithelium. Am J Physiol 273:C1168–C1175

    PubMed  CAS  Google Scholar 

  • Glover D, Riley L, Carmichael K et al. (1983) Hypocalcemia and inhibition of parathyroid hormone secretion after administration of WR-2721 (a radioactive and chemoprotective agent). N Engl J Med 309:1137–1147

    Article  PubMed  CAS  Google Scholar 

  • Gogusey J, Duchambon P, Hory B et al. (1997) Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 51:328–326

    Article  Google Scholar 

  • Goodmann WG, Veldhuis JD, Belin TR, Herle AJ van, Juppner H, Salusky IB (1998) Calcium-sensing by parathyroid glands in secondary hyperparathyroidism. J Clin Endocrinol Metab 83:2765–2772

    Article  Google Scholar 

  • Grieco M, Santoro M, Berlingieri MT et al. (1990) PTC is a novel rearranged form of the RET proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60:557–563

    Article  PubMed  CAS  Google Scholar 

  • Guise TA (1997) Parathyroid hormone-related protein and bone metastases. Cancer 80:1572–1580

    Article  PubMed  CAS  Google Scholar 

  • Guise TA, Yin JJ, Taylor SD et al. (1996) Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest 98:1544–1549

    Article  PubMed  CAS  Google Scholar 

  • Hakim JP, Levine MA (1994) Absence of p53 point mutations in parathyroid adenoma and carcinoma. J Clin Endocrinol Metab 78:103–106

    Article  PubMed  CAS  Google Scholar 

  • Hall JG (1997) Genomic imprinting: nature and clinical relevance. Annu Rev Med 48:35–44

    Article  PubMed  CAS  Google Scholar 

  • Heath H (1989) Familial benign (hypocalciuric) hypercalcemia. A trouble-some mimic of mild primary hyperparathyroidism. Med Clin North Am 18:723–740

    Google Scholar 

  • Heath DA (1994) Familial hypocalciuric hypercalcemia. In: Bilezikan JP (ed) The parathyroids. Raven Press, New York, pp 699–710

    Google Scholar 

  • Heath III H, Odelberg S, Jackson CE et al. (1996) Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. J Clin Endocrinol Metab 81:1312–1317

    Article  PubMed  CAS  Google Scholar 

  • Heppner C, Kester MB, Agarwal SK et al. (1997) Somatic mutation of the MEN 1 gene in parathyroid tumours. Nat Genet 16:375–378

    Article  PubMed  CAS  Google Scholar 

  • Hosokawa Y, Pollak MR, Brown EM, Arnold A (1995) Mutational analysis of the extracellular Ca2+-sensing receptor gene in human parathyroid tumors. J Clin Endocrinol Metab 80:3107–3110

    Article  PubMed  CAS  Google Scholar 

  • Hsi ED, Zukerberg LR, Yang W-I, Arnold A (1996) Cyclin DI/PRADI expression in parathyroid adenomas: an immunohistological study. J Clin Endocrinol Metab 81:1736–1739

    Article  PubMed  CAS  Google Scholar 

  • Huang SM, Duh QY, Shaver J, Siperstein AE, Kraimps JL, Clark OH (1997) Familial hyperparathyroidism without multiple endocrine neoplasia. World J Surg 21:22–28

    Article  PubMed  CAS  Google Scholar 

  • Hurwitz S (1996) Homeostatic control of plasma calcium concentration. Crit Rev Biochem Mol Biol 31:41–100

    Article  PubMed  CAS  Google Scholar 

  • Isotani H, Fukumoto Y, Kawamura H et al. (1996) Hypoparathyroidism and insulin-dependent diabetes mellitus in a patient with Kearns-Sayre syndrome harbouring a mitochondrial DNAdeletion. Clin Endocrinol (Oxf) 45:637641

    Article  Google Scholar 

  • Jackson CE, Norum RA, Boyd SB et al. (1990) Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome. Surgery 108:1006–1013

    PubMed  CAS  Google Scholar 

  • Jenkins PJ, Satta MA, Simmgen M et al. (1997) Metastatic parathyroid carcinoma in the MEN 2A syndrome. Clin Endocrinol 47:747–751

    Article  CAS  Google Scholar 

  • Jobert AS, Zhang P, Couvineau A et al. (1998) Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J Clin Invest 102:34–40

    Article  PubMed  CAS  Google Scholar 

  • Juppner H, Schipani E, Basteppe M et al. (1998) The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds the chromosome 20q13.3. Proc Natl Acad Sci USA 95:11798–11803

    Article  PubMed  CAS  Google Scholar 

  • Karaplis AC, SKL, Baba H, Arnold A, Kronenberg HM (1995) Inefficient membrane targeting, translocation, and proteolytic processing by signal peptidase of a mutant prepropa rathyro id hormone protein. J Biol Chem 270:1629–1635

    Article  PubMed  CAS  Google Scholar 

  • Kassem M, Zhang X, Brask S, Eriksen E, Mosekilde L, Kruse T (1994) Familial isolated hyperparathyroidism. Clin Endocrinol (Oxf) 41:415–420

    Article  CAS  Google Scholar 

  • Khosla S, Ebeling PR, Firek AF, Burritt MM, Kao PC, Heath III H (1993) Calcium infusion suggests a “set-point” abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperp arathyroidism. J Clin Endocrinol Metab 76:715–720

    Article  PubMed  CAS  Google Scholar 

  • Kifor O, Moore FD, Wang P et al. (1996) Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 81:1598–1606

    Article  PubMed  CAS  Google Scholar 

  • Kimura T, Yoshimoto K, Tanaka C et al. (1996) Obvious mRNA and protein expression but absence of mutations of the RET proto-oncogene in parathyroid tumors. Eur J Endocrinol 134:314–319

    Article  PubMed  CAS  Google Scholar 

  • Kobayashi M, Tanaka H, Tsuzuki K et al. (1997) Two novel missense mutations in calcium-sensing receptor gene associated with neonatal severe hyperparathyroidism. J Clin Endocrinol Metab 82:2716–2719

    Article  PubMed  CAS  Google Scholar 

  • Kraimps J-L, Denizot A, Carnaille B et al. (1996) Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. World J Surg 20:808–813

    Article  PubMed  CAS  Google Scholar 

  • Laitinen K, Lamberg AC, Tunninen R, Karonen SL, Tahtela R, Ylikahri R, Valimaki M (1991) Transient hypoparathyroidism during acute alcohol intoxication. N Engl J Med 324:721–727

    Article  PubMed  CAS  Google Scholar 

  • Larsson C, Skogseid B, Öberg K, Nakamura Y, Nordenskjöld M (1988) Multiple endocrine neoplasia type 1 gene maps to chromosome II and is lost in insuloma. Nature 332:85–87

    Article  PubMed  CAS  Google Scholar 

  • Law WM, Hodgson SF, Heath H (1983) Autosomal recessive inheritance of familial hyperparathyroidism. N Engl J Med 306:650–653

    Article  Google Scholar 

  • Levine MA, Spiegel AM (1995) Pseudohypoparathyroidism. In: DeGroot LJ, Besser M, Burger HG (eds) Endocrinology. Saunders, Philadelphia, pp 1136–1150

    Google Scholar 

  • Levine MA, Downs RW, Moses AM et al. (1983) Resistance to multiple hormones in patients with pseudohypoparathyroidism. Associated with deficient activity of guanine nucleotide regulatory protein. Am J Med 74:545–556

    Article  PubMed  CAS  Google Scholar 

  • Levine MA, Ahn TG, Klupt SF et al. (1988) Genetic deficiency of the alpha subunit of the guanine nucleotidebinding Gs as the molecular basis for Albright hereditary osteodystrophy. Proc Natl Acad Sci USA 85:617–621

    Article  PubMed  CAS  Google Scholar 

  • Lippuner K, Zehnder H-J, Casez J-P, Takkinen R, Jaeger P (1996) PTH-related protein is released into the mother’s bloodstream during lactation: evidence for beneficial effects on maternal calcium-phosphate metabolism. J Bone Miner Res 11:1394–1399

    Article  PubMed  CAS  Google Scholar 

  • LiVolsi VA (1994) Embryology, anatomy, and pathology of the parathyroids. In: Bilezikian JP (ed) The parathyroids, basic and clinical concepts. Raven Press, New York, pp 1–14

    Google Scholar 

  • Lubensky IA, Debelenko LV, Zhuang Z et al. (1996) Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN 1 patients. Cancer Res 56:5272–5278

    PubMed  CAS  Google Scholar 

  • Moraes CT, DiMauro S, Zeviani M et al. (1989) Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome (see comments). N Engl J Med 320:1293–1299

    Article  PubMed  CAS  Google Scholar 

  • Morten KJ, Cooper JM, Brown GK, Lake BD, Pike D, Poulton I (1993) A new point mutation associated with mitochondrial encephalomyopathy. Hum Mol Genet 2:2081–2087

    Article  PubMed  CAS  Google Scholar 

  • Motokura T, Arnold A (1993) PRADI/cyclin D I proto-oncogene: genomic organization, 5’ DNA sequence of a tumor-specific rearrangement breakpoint. Genes Chromosomes Cancer 7:89–95

    Article  PubMed  CAS  Google Scholar 

  • Muller W, Peter HH, Wilken M et al. (1988) The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome. Eur I Pediatr 147:496–502

    Article  CAS  Google Scholar 

  • Mumm S, Whyte MP, Thakker RV, Buetow KH, Schlessinger D (1997) mtDNA analysis shows common ancestry in two kindreds with X-linked recessive hypoparathyroidism and reveals a heteroplasmic silent mutation. Am J Hum Genet 60:153–159

    PubMed  CAS  Google Scholar 

  • Nagant de Deuxchaisnes C, Krane SM (1978) Hypoparathyroidism. In: Avioli CV, Krane SM (eds) Metabolie bone disease. Academic Press, New York, pp 218–245

    Google Scholar 

  • Padberg B-C, Sehröder S, Jochum W et al. (1995) Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland. Am I Pathol 147:1600–1607

    CAS  Google Scholar 

  • Palanisamy N, Imanishi Y, Rao PH, Tahara H, Chaganti RSK, Arnold A (1998) Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenoma. J Clin Endocrinol Metab 83:1766–1770

    Article  PubMed  CAS  Google Scholar 

  • Parfitt AM (1994) Parathyroid growth, normal and abnormal. In: Bilezikian JP (ed) The parathyroids. Raven Press, New York, pp 373–405

    Google Scholar 

  • Parkinson DB, Thakker RV (1992) A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism. Nat Genet 1:149–152

    Article  PubMed  CAS  Google Scholar 

  • Pearce SHS, Brown EM (1996) The genetic basis of endocrine disease. Disorders of calcium ion sensing. J Clin Endocrinol Metab 81:2030–2035

    Article  PubMed  CAS  Google Scholar 

  • Pearce SH, Williamson C, Kifor O et al. (1996) A familial syndrome of hypocalcemia with hypercaleiuria due to mutations in the calcium-sensing receptor (see comments). N Engl J Med 335:1115–1122

    Article  PubMed  CAS  Google Scholar 

  • Pellock JM, Behrens M, Lewis L, Holub D, Carter S, Rowland LP (1978) Kearns-Sayre syndrome and hypoparathyroidism. Ann Neurol 3:455–458

    Article  PubMed  CAS  Google Scholar 

  • Pollack MR, Brown EM, Chou Y-HW et al. (1993) Mutations in the human Ca2+-sensing receptor gene cause familial hypocaleiuric hyper calcemia and neonatal severe hyperparathyroidism. Cell 75:1297–1303

    Article  Google Scholar 

  • Pollak MR, Brown EM, Estepp HL et al. (1994) Autosomaldominant hypocalcemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet 8:303–307

    Article  PubMed  CAS  Google Scholar 

  • Pott JT (1996) Hyperparathyroidism and other hypercalcemic disorders. Adv Intern Med 41:165–212

    Google Scholar 

  • Raue F, Frank-Raue K, Grauer A (1994) Multiple endocrine neoplasia type 2, clinical features and screening. Endocrinol Metab Clin North Am 23:137–156

    PubMed  CAS  Google Scholar 

  • Raue F, Kraimps JL, Dralle H et al. (1995) Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Intern Med 238:369–373

    Article  PubMed  CAS  Google Scholar 

  • Rizzoli R, Pache J-C, Didierjean L, Bürger A, Bonjour l-P (1994) A thymoma as a cause of true ectopic hyperparathyro idism. J Clin Endocrinol Metab 79:912–915

    Article  PubMed  CAS  Google Scholar 

  • Roskams T, Desmet V (1997) Parathyroid hormone-related peptides. A new class of multifunctional proteins. Am J Pathol 150:779–785

    PubMed  CAS  Google Scholar 

  • Sabry MA, Zaki M, Abul HS et al. (1998) Kenny-Caffey syndrome is part of the CATCH 22 haploinsuffieiency cluster. J Med Genet 35:31–36

    Article  PubMed  CAS  Google Scholar 

  • Santoro M, Carlomagno F, Romano A et al. (1995) Activation of RET as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B. Science 267:381–383

    Article  PubMed  CAS  Google Scholar 

  • Sarkar G, Sommer SS (1989) Access to a messenger RNA sequence or its protein products is not limited by tissue or species specificity (see comment s). Science 244:331–334

    Article  PubMed  CAS  Google Scholar 

  • Scambler PI, Carey AH, Wyse RK et al. (1991) Microdeletion within 22q11 associated with sporadic anf familial DiGeorge syndrome. Genomics 10:201–206

    Article  PubMed  CAS  Google Scholar 

  • Schilling T, Ziegler R (1996) The diagnosis and therapy of hypoparathyroidism. Dtsch Med Wochenschr 121:841–844

    Article  PubMed  CAS  Google Scholar 

  • Schilling T, Ziegler R (1997) Current therapy of hypoparathyroidism — a survey of German endocrinology centers. Exp Clin Endocrinol Diabetes 105:237–241

    Article  PubMed  CAS  Google Scholar 

  • Schipani E, Weinstein LS, Bergwitz C et al. (1995) Pseudohypoparathyroidism type Ib ist not caused by mutations in the coding exons of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene. J Clin Endocrinol Metab 80:1611–1621

    Article  PubMed  CAS  Google Scholar 

  • Schipani E, Langman CB, Parfitt AM et al. (1996) Constitutively act ivated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen’s metaphyseal condrodysplasia. N Engl J Med 335:708–714

    Article  PubMed  CAS  Google Scholar 

  • Schmitt CP, Schaefer F, Bruch A et al. (1996) Control of pulsatile and tonie parathyroid hormone secretion by ionized calcium. J C!in Endocrinol Metab 81:4236–4243

    Article  CAS  Google Scholar 

  • Schuffenecker I, Virally-Monod M, Brohet R et al. (1998) Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2 A families with mutations at codon 634 of the RET proto-oncogene. Groupe d’etude des tumeurs a caleitonine. J Clin Endocrinol Metab 83:487–491

    Article  PubMed  CAS  Google Scholar 

  • Sherr CJ (1996) Cancer cell cycles. Science 274:1672–1677

    Article  PubMed  CAS  Google Scholar 

  • Szabo J, Heath B, Hill VM et al. (1995) Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome lq21-q31. Am J Hum Genet 56:944–950

    PubMed  CAS  Google Scholar 

  • Tahara H, Smith AP, Gaz RD, Arnold A (1996) Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas. J Clin Endocrinol Metab 81:3663–3667

    Article  PubMed  CAS  Google Scholar 

  • Tahseen K, Khan S, Uma R et al. (1997) Kenny-Caffey syndrome in sex Bedouin sibships: autosomal recessive inheritance is confirmed. Am J Med Genet 69:126–132

    Article  PubMed  CAS  Google Scholar 

  • Teh B, Farnebo F, Kristoffersson U et al. (1996) Autosomaldominant primary hyperparathyroidism and jaw tumour syndrome associated with renal hamartomas and cystic kidney disease: linkage to lq21-q32 and loss of heterozygosity of the wold type allele in renal hamartomas. J Clin Endocrinol Metab 81:4204–4211

    Article  PubMed  CAS  Google Scholar 

  • Thakker RV, Davies KE, Whyte MP, Wooding G, O’Riordan JL (1990) Mapping the gene causing X-linked recessive idiopathic hypoparathyroidism to Xq26-Xq27 by linkage studies. J Clin Invest 86:40–45

    Article  PubMed  CAS  Google Scholar 

  • Thompson DB, Samowitz WS, Odelberg S, Davis RK, Szabo J, Heath III H (1995) Genetic abnormalities in sporadie parathyroid adenomas: loss of heterozygosity for chromosome 3q markers flanking the calcium receptor locus. J C!in Endocrinol Metab 80:3377–3380

    Article  CAS  Google Scholar 

  • Trump D, Farren B, Wooding C et al. (1996) Clinieal study of multiple endocrine neoplasia type 1 (MEN 1). Q J Med 89:653–669

    Article  CAS  Google Scholar 

  • Wilichowski E, Gruters A, Kruse K et al. (1997) Hypoparathyroidism and deafness associated with pleioplasmic large scale rearrangements of the mitochondrial DNA: a clinical and molecular genetic study of four children with Kearns-Sayre syndrome. Pediatr Res 41:193–200

    Article  PubMed  CAS  Google Scholar 

  • Williamson C, Cavaco BM, Jausch A et al. (1999) Mapping the gene causing hereditary primary hyperparathyroidism in a Portuguese kindred to chromosome lq22-q31. J Bone Miner Res 14:230–239

    Article  PubMed  CAS  Google Scholar 

  • Wortsman J, Kumar V (1994) Case report: idiopathic hypoparathyroidism co-existing with celiac disease: immunologic studies. Am J Med Sci 307:420–427

    Article  PubMed  CAS  Google Scholar 

  • Wynne AG, Heerden J van, Carney JA, Fitzpatriek LA (1992) Parathyroid carcinoma: clinical and pathological features in 43 patients. Medicine (Baltimore) 71:197–205

    CAS  Google Scholar 

  • Yu S, Yu D, Hainline BE et al. (1995) A deletion hot-spot in exon 7 of the Gs alpha gene (GNAS1) in patients with Albright hereditary osteodystrophy. Hum Mol Genet 4:2001–2002

    Article  PubMed  CAS  Google Scholar 

  • Zahrani AA, Levine MA (1996) Primary hyperparathyroidism. Lancet 349:1233–1266

    Article  Google Scholar 

  • Zlotogora J, Shapiro MS (1992) Polyglandular auto immune syndrome type I among Iranian Jews, J Med Genet 29:824–826

    Article  PubMed  CAS  Google Scholar 

  • Zucchi I, Mumm S, Pila G et al. (1996) YAC/STS map across 12 Mb of Xq27 at 25-kb resolution, merging Xq26-qter. Genomies 34:42–54

    Article  CAS  Google Scholar 

  • Zupanc ML, Moraes CT, Shanske S, Langman CB, Ciafaloni E, DiMauro S (1991) Deletion of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndromes. Ann Neurol 29:680–683

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Raue, F., Schilling, T. (2001). Hyper- und Hypoparathyreoidismus. In: Ganten, D., Ruckpaul, K., Janssen, O.E., Heufelder, A.E. (eds) Molekularmedizinische Grundlagen von Endokrinopathien. Molekulare Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56858-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56858-9_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-63216-7

  • Online ISBN: 978-3-642-56858-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics